Lilly wins Alimta Vitamin Regimen Patent Lawsuit against Apotex Inc
By Akshay Kedari  Date: 2019-12-31

Lilly wins Alimta Vitamin Regimen Patent Lawsuit against Apotex Inc

 

  • Ruling by the US District Court has concluded that Apotex Inc. would be infringing the Alimta vitamin regimen patent by launching its proposed products until the patent expiration of Lilly
     
  • The ruling would bar Apotex from marketing its alternative product until the patent expiration in May 2022

American pharmaceutical company, Eli Lilly and Company, announced that the U.S. District Court (Southern District of Indiana) decided in favor of the company in the Alimta Vitamin Regimen Patent Lawsuit. The court's verdict states that Apotex Inc, a competitor would be liable for infringement of Alimta vitamin regimen patent in the event the company selling generics of the drug prior to the expiration of the patent in May 2022. 

 

Apotex is a Canadian pharmaceutical corporation producing high-quality, affordable generic, as well as innovative pharmaceuticals, for patients across the globe. The ruling would prevent Apotex from marketing its generic form of the lung cancer drug Alimta. Lilly expects the competitor company to appeal the ruling. 

 

For the record, Alimta vitamin regimen is categorized as an antifolate drug, which is designed to bar cells from making DNA through the use of folic acid.

 

Lilly's senior vice president and general counsel, Michael J. Harrington was quoted saying that the company is pleased with the District Court's ruling finding the competitor’s proposition to be a case of infringement. Commenting further on the verdict Harrington stated that Lilly deserves intellectual property protection for its extensive research efforts concentrated on the discovery of the Alimta vitamin regimen. 

 

The Patent Trial and Appeal Board of the U.S. Patent and Trademark Office had also ruled in favor of the company in 2017. Similarly, the U.S. Court of Appeals for the Federal Circuit also upheld the validity of the patent in 2017. 

 

Source credit:

https://investor.lilly.com/news-releases/news-release-details/us-district-court-rules-favor-lilly-alimta-vitamin-regimen-0

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Lab-grown, no-kill meat to be put on sale in Singapore for first time
Lab-grown, no-kill meat to be put on sale in Singapore for first time
By Akshay Kedari

Cultured, lab-grown meat, produced inside bioreactors without slaughtering any animals, has reportedly been approved to go on sale for the first time by regulatory authorities in Singapore. The new development is being hailed as a momentous, landmark...

Chancellor Rishi Sunak pledges £100bn to transform UK’s infrastructure
Chancellor Rishi Sunak pledges £100bn to transform UK’s infrastructure
By Akshay Kedari

As per the statement of chancellor Rishi Sunak, Britain’s first nationwide infrastructure plan would provide a “once in a lifetime investment” of approximately £100 billion to drive the nation’s recovery from the COVID-1...

Telus Communications selects Nokia to deliver 5G services in Canada
Telus Communications selects Nokia to deliver 5G services in Canada
By Akshay Kedari

According to reliable sources, Nokia Corporation has reportedly been selected by Canada-based Telus Communications Inc. to provide 5G services in Canada. The Finnish multinational technology giant will reportedly support the Canadian mobile service o...

TBI, Oracle to jointly launch cloud-based vaccine management system
TBI, Oracle to jointly launch cloud-based vaccine management system
By Akshay Kedari

Tony Blair Institute (TBI) and Oracle have recently introduced cloud technology to Africa for effective management of public health programs in the region. As per credible sources, initially, Ghana, Sierra Leone and Rwanda will use the new Oracl...

Minerva Bunkering unveils ADP for better clarity in bunker deliveries
Minerva Bunkering unveils ADP for better clarity in bunker deliveries
By Akshay Kedari

Swiss supplier of marine fuels Minerva Bunkering has reportedly introduced an innovative solution called Advanced Delivery Platform (ADP) in a bid to increase efficiency and transparency during bunkering operations. According to reliable sources, Min...